Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03030378
Brief Title: Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

First Submitted : January 24, 2017
First Submitted that Met QC Criteria : January 24, 2017
First Posted : January 25, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : February 11, 2020
Last Update Posted : February 12, 2020